Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Endonovo Therapeutics (ENDV) Preferred Shares Issued (2018 - 2020)

Endonovo Therapeutics has reported Preferred Shares Issued over the past 2 years, most recently at $50000.0 for Q1 2020.

  • Quarterly results put Preferred Shares Issued at $50000.0 for Q1 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $50000.0 (changed N/A YoY), and the annual figure for FY2020 was $50000.0, down 80.39%.
  • Preferred Shares Issued for Q1 2020 was $50000.0 at Endonovo Therapeutics, up from -$482498.0 in the prior quarter.
  • Over the last five years, Preferred Shares Issued for ENDV hit a ceiling of $280000.0 in Q3 2018 and a floor of -$482498.0 in Q4 2018.